Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

<p>Original picture</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Xiaodong Shu (16721586) (author)
Άλλοι συγγραφείς:	Jianjie Li (16721589) (author), Un In Chan (16721592) (author), Sek Man Su (16721595) (author), Changxiang Shi (16721598) (author), Xin Zhang (16721601) (author), Tingting An (16721604) (author), Jun Xu (16721607) (author), Lihua Mo (16721610) (author), Jianlin Liu (16721613) (author), Yuqing Wang (16721616) (author), Xiaoling Li (16721619) (author), Min Deng (16721622) (author), Josh Haipeng Lei (16721625) (author), Chunfei Wang (16721628) (author), Hao Tian (16721631) (author), Sun Heng (16721634) (author), Joong Sup Shim (16721637) (author), Xuanjun Zhang (16721640) (author), Yunlu Dai (16721643) (author), Zhicheng Yao (16721646) (author), Xiaying Kuang (16721649) (author), Ying Lin (15293140) (author), Chu-Xia Deng (16721652) (author), Xiaoling Xu (16721655) (author)
Έκδοση:	2025
Θέματα:	Cancer Cancer Biology Tumor Biology Immuno-oncology Breast Cancer Immunology Immunotherapy Checkpoint blockade Oncogenes & Tumor Suppressors Progression, Invasion & Metastasis Tumor Microenvironment
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
ανά: Christine Pich-Bavastro (16509238)
Έκδοση: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
ανά: Kankan Cao (16437263)
Έκδοση: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
ανά: Sung-Eun Lee (14855067)
Έκδοση: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
ανά: Aleksandar Obradovic (7549517)
Έκδοση: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
ανά: Aleksandar Obradovic (7549517)
Έκδοση: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
ανά: Ruiyun Zhang (17142498)
Έκδοση: (2025)

Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
ανά: Clare Vesely (505402)
Έκδοση: (2025)

Supplementary Figures from NKG7 Is Required for Optimal Antitumor T-cell Immunity
ανά: Xian-Yang Li (15022958)
Έκδοση: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
ανά: Arianna Draghi (15126339)
Έκδοση: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
ανά: Arianna Draghi (15126339)
Έκδοση: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
ανά: Arianna Draghi (15126339)
Έκδοση: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
ανά: Renumathy Dhanasekaran (14962092)
Έκδοση: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
ανά: Sonia A. Patel (15055688)
Έκδοση: (2025)

Supplementary video 1 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
ανά: Alvaro Teijeira (14962650)
Έκδοση: (2025)

Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
ανά: Alvaro Teijeira (14962650)
Έκδοση: (2025)

Supplementary video 3 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
ανά: Alvaro Teijeira (14962650)
Έκδοση: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
ανά: Hansol Lee (15054787)
Έκδοση: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qk82u0gcg7qlb4omvhdmcfc4te